NASDAQ:INSY
Delisted

Insys Therapeutics Stock Insider Trading

$0.255
+0 (+0%)
At Close: Sep 17, 2019
Date Action Amount Person Type
Apr 17, 2019 Buy 72 674 Long Andrew G Employee Stock Option (right to buy)
Apr 17, 2019 Buy 12 475 Long Andrew G Common Stock
Mar 04, 2019 Buy 20 935 Lapalme Pierre Employee Stock Option (right to buy)
Mar 04, 2019 Buy 8 083 Lapalme Pierre Common Stock
Jan 25, 2019 Buy 70 000 Nance Mark E Employee Stock Option (right to buy)
Jan 25, 2019 Buy 10 000 Nance Mark E Common Stock
Jan 25, 2019 Buy 173 000 Long Andrew G Employee Stock Option (right to buy)
Jan 25, 2019 Buy 29 000 Long Andrew G Common Stock
Oct 10, 2018 Buy 100 000 Nance Mark E Employee Stock Option (right to buy)
Oct 10, 2018 Buy 15 000 Nance Mark E Common Stock
Oct 10, 2018 Buy 0 Nance Mark E
Aug 07, 2018 Sell 5 000 Long Andrew G Restricted Stock Units
Aug 07, 2018 Buy 5 000 Long Andrew G Common Stock
Mar 05, 2018 Buy 42 400 Long Andrew G Employee Stock Option (right to buy)
Mar 05, 2018 Buy 10 600 Long Andrew G Common Stock
Mar 05, 2018 Buy 16 000 Lapalme Pierre Employee Stock Option (right to buy)
Mar 05, 2018 Buy 4 000 Lapalme Pierre Common Stock
Feb 21, 2018 Buy 4 000 Lapalme Pierre Common Stock
Feb 21, 2018 Sell 4 000 Lapalme Pierre Restricted Stock Units
Nov 17, 2017 Buy 15 000 Long Andrew G Stock Option (right to buy)
Aug 07, 2017 Buy 100 000 Long Andrew G Employee Stock Option (right to buy)
Aug 07, 2017 Buy 15 000 Long Andrew G Restricted Stock Units
Aug 07, 2017 Buy 0 Long Andrew G
Feb 21, 2017 Buy 16 000 Lapalme Pierre Employee Stock Option (right to buy)
Feb 21, 2017 Buy 4 000 Lapalme Pierre Restricted Stock Units
Feb 21, 2017 Buy 56 000 Vetticaden Santosh Employee Stock Option (right to buy)
Feb 21, 2017 Buy 14 000 Vetticaden Santosh Restricted Stock Units
Jan 12, 2017 Buy 30 000 Vetticaden Santosh Employee Stock Option (right to buy)
Jan 09, 2017 Buy 0 Vetticaden Santosh Common Stock
Jan 09, 2017 Buy 140 000 Vetticaden Santosh Employee Stock Option (right to buy)
Jan 09, 2017 Buy 84 699 Vetticaden Santosh Employee Stock Option (right to buy)
Aug 09, 2016 Sell 5 781 Brennan Daniel Common Stock
May 02, 2016 Buy 25 000 Lapalme Pierre Stock Option (right to buy)
Nov 04, 2015 Buy 0 Brennan Daniel Common Stock
Nov 04, 2015 Buy 250 000 Brennan Daniel Stock Option (right to buy)
May 05, 2015 Buy 9 000 Lapalme Pierre Stock Option (right to buy)
Aug 07, 2014 Buy 9 000 Lapalme Pierre Stock Option (right to buy)
May 24, 2013 Buy 2 000 Lapalme Pierre Common Stock
May 24, 2013 Buy 1 000 Lapalme Pierre Common Stock
May 14, 2013 Buy 20 000 Lapalme Pierre Stock Option (right to buy)
May 02, 2013 Buy 24 590 Lapalme Pierre Stock Option (Right to Buy)
INSIDER POWER
0
Last 41 transactions
Buy: 1 408 456 | Sell: 14 781 (Shares)

Based on the 41 latest insides trades, we have calculated the insider power to be negative at a ratio of 0.000.

In total, the insiders bought 1 408 456 and sold 14 781 INSY shares in the last 41 trades.

Click to get the best stock tips daily for free!

About Insys Therapeutics

Insys Therapeutics Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients in the United States. Its lead product candidate is Syndros, an orally administered liquid formulation of dronabinol. The company is also developing Cannabidiol Oral Solution, a synthetic cannabidiol for childhood ... INSY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT